Disseminated malignant neoplasm, unspecified
- C80.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2025 edition of ICD-10-CM C80.0 became effective on October 1, 2024.
- This is the American ICD-10-CM version of C80.0 – other international versions of ICD-10 C80.0 may differ.
Applicable To
- Carcinomatosis NOS
- Generalized cancer, unspecified site (primary) (secondary)
- Generalized malignancy, unspecified site (primary) (secondary)
The following code(s) above C80.0 contain annotation back-references
that may be applicable to C80.0:
Approximate Synonyms
- Adenocarcinoma carcinomatosis
- Cancer of the ovary, disseminated
- Cancer of the vulva, disseminated
- Cancer of vulva, disseminated
- Cancer, carcinomatosis
- Cancer, carcinomatosis squamous cell
- Cancer, carcinomatosis, adenocarcinoma
- Cancer, carcinomatosis, small cell
- Cancer, carcinomatosis, undifferentiated lg cell
- Cancer, disseminated
- Carcinomatosis
- Carcinomatosis melanoma
- Melanoma, carcinomatosis
- Ovarian cancer, disseminated
- Small cell carcinoma carcinomatosis
- Squamous cell carcinomatosis
- Undifferentiated large cell carcinomatosis
- Widespread metastatic malignant neoplastic disease
Clinical Information
- A condition in which cancer is spread widely throughout the body, or, in some cases, to a relatively large region of the body.
- Carcinoma that has spread diffusely to an anatomic site or throughout the body.
ICD-10-CM C80.0 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
- 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
- 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc
Convert C80.0 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to C80.0:
- Type 1 Excludes: C79.9, C79.9
Diagnosis Index entries containing back-references to C80.0:
- Carcinoma (malignant) – see also Neoplasm, by site, malignant
- generalized, with unspecified primary site C80.0
- Carcinomatosis C80.0
- unspecified site C80.0 (primary) (secondary)